Skip to content

GREENVEIL

  • beauty
  • industrial
  • pharma

Meglumine

CAS 133-52-8

Also registered as 17 other CAS numbers

31566-24-2 · 45081-44-5 · 50560-29-7 · 53418-31-8 · 61919-50-4 · 97780-33-1 · 131133-75-0 · 131337-57-0 · 168828-98-6 · 170034-45-4 · 184169-59-3 · 224432-61-5 · 768396-31-2 · 887770-59-4 · 901768-29-4 · 2230289-31-1 · 6284-40-8

Meglumine chemical structure

Concern score

Not assessed — no hazard data yet.

Meglumine in plain language

What it is

On cosmetic ingredient lists it appears as “Methylglucamine”.

Also known as Methylglucamine · N-methylglucamine · (2R,3R,4R,5S)-6-(Methylamino)hexane-1,2,3,4,5-pentol · N-Methyl-D-glucamine · 1-Deoxy-1-(methylamino)-D-glucitol · D-glucitol, 1-DEOXY-1-(METHYLAMINO)-

Show all 18 names

N-methylsorbitylamine · 1-Deoxy-1-methylaminosorbitol · D-(-)-N-Methylglucamine · G20950LN · Glucamine (d), n-methyl-, (-)- · Glucitol, 1-deoxy-1-(methylamino)-, D- · GlyTouCan:G20950LN · Meglumin · P01CB01 · antimoniate de mAglumine · D(-)-n-methylglucamine · Megluminum

What it does

Used in cosmetics as a hair conditioner.

  • Hair conditioning
  • Conditioner
Is it a concern?
We haven't assessed a concern score for this ingredient yet. It is listed for cosmetic use in the EU.

Regulation

No restrictions found. Meglumine appears in these published regulatory listings.

  • Inactive ingredient in US drugs

Recorded in these product areas

  • Found in consumer products
  • Industrial
  • USFDAinactive ingredient database10 entries — 4 administration routes
    • Route: INTRAMUSCULAR; Dosage form: INJECTION; Potency: 144.76 mgSource →
    • Route: INTRAVASCULAR; Dosage form: INJECTION; Potency: ADJ PHSource →
    • Route: INTRAVENOUS; Dosage form: INJECTION; Potency: 154 mgSource →
    • Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 75 mgSource →
    • Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NASource →
    • Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 21 mgSource →
    • Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 4 mgSource →
    • Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 25 mgSource →
    • Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 10 mgSource →
    • Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 5 mgSource →
  • EUCosIngActiveListed in CosIng inventory for cosmetic use.
    • Listed in CosIng inventory for cosmetic use.Source →
  • USEPAcommercial use observedEPA CPDat observed this chemical in 3 composition records across product categories including Laboratory supplies. EPA CPDat classifies this chemical for functional uses including Softener and conditioner.
    • EPA CPDat observed this chemical in 3 composition records across product categories including Laboratory supplies. EPA CPDat classifies this chemical for functional uses including Softener and conditioner.Source →
  • USFDAlisted in openFDA substanceopenFDA substance registry classifies this ingredient as chemical.
    • openFDA substance registry classifies this ingredient as chemical.Source →

Expert safety opinions

No expert opinion on file for Meglumine. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.

  • SCCS

    EU Scientific Committee on Consumer Safety

    No SCCS opinion on file.

  • CIR

    Cosmetic Ingredient Review (US expert panel)

    No CIR safety assessment on file.

Evidence & sources

No graded research studies for Meglumine yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

7 data sources

Where this comes from

  • CosIng

    regulatory · updated 2026-09-23

    Open →

  • EPA Chemical and Products Database

    exposure · updated 2019-12-20

    Open →

  • EPA DSSTox Identifiers

    chemistry · updated 2025-12-29

    Open →

  • FDA Inactive Ingredient Database

    regulatory · updated 2026-01-09

    Open →

  • FDA GSRS UNII

    registry · updated 2026-02-26

    Open →

  • openFDA Substance

    registry · updated 2026-05-24

    Open →

  • PubChem Live Enrichment

    chemistry · updated 2026-05-17

    Open →

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.

Where it has been recorded

How often EPA CPDat has listed Meglumine in a product composition. These are source records, not Greenveil catalog products.

Source records

3

Named organisations

2

Laboratory supplies

Typical roles

Hair conditioningConditioner
See products using Meglumine →